Overview on physicochemical properties and cellular activities of three-branched CRBN ligands and PROTACs.
Cmpd | log D7.4a | CHIIAMb | % HSA bindingc | K i/Kdd (μM) | DC50e (nM) | % BRD4f deg. |
---|---|---|---|---|---|---|
9 | 1.7 | 21.1 | 81 | 0.2 ± 0.7 | n.d.g | n.d. |
11 | 3.2 | n.d. | n.d. | 11.0 ± 13.5h | n.d. | n.d. |
13a | 3.1 | 34.5 | 94 | n.d. | 6.1 ± 2.4 | 95 |
13b | 2.5 | 29.6 | 91 | n.d. | 88 ± 53 | 38 |
13c | 2.5 | 29.2 | 90 | n.d. | 162 ± 41 | 22 |
13d | 2.5 | 28.7 | 90 | n.d. | 83 ± 80 | 52 |
Distribution coefficients at pH 7.4 were estimated by an HPLC-based method.
Chromatographic hydrophobicity index values referring to IAM chromatography (CHIIAM values), an estimate for drug-membrane interactions and permeability.28
Protein binding values were estimated by an HPLC-based method.
Affinity values determined in a competitive MST assay as described in the Method sections (see ESI).
Concentration at which 50% of BRD4 has been degraded after 24 h treatment of Namalwa cells with each compound ranging from 0.1 to 1000 nM.
Percentage of degraded BRD4 after 24 h treatment of Namalwa cells with 0.1 μM of each compound.
Not determined.
Affinity was determined as a Kdvia initial fluorescence and is reported in place of the Ki.